Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment.

Kuo-Hao HoTzu-Wen HuangChwen-Ming ShihYi-Ting LeeAnn-Jeng LiuPeng-Hsu ChenKu-Chung Chen

Published in: BMC medicine (2021)

We identified a subgroup of cancer patients stratified by glycolysis-associated lncRNAs with poor prognoses, high immune infiltration, and EMT activation, thus providing new directions for cancer therapy.

Keyphrases

cancer therapy
stem cells
network analysis
randomized controlled trial
clinical trial